Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Orange, California and other locations
Dates
study started
completion around
Principal Investigator
by Xiao-Tang Kong

Description

Summary

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.

Official Title

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma

Details

Keywords

Grade II Meningioma, Intracranial Meningioma, Meningioma, Clinical Observation, Radiation Therapy

Eligibility

Locations

  • UC Irvine Health/Chao Family Comprehensive Cancer Center accepting new patients
    Orange California 92868 United States
  • Kaiser Permanente-Anaheim accepting new patients
    Anaheim California 92806 United States
  • Kaiser Permanente-Bellflower accepting new patients
    Bellflower California 90706 United States
  • Kaiser Permanente-Ontario accepting new patients
    Ontario California 91761 United States

Lead Scientist at UC Irvine

  • Xiao-Tang Kong
    Health Sciences Professor, Neurology, School of Medicine. Authored (or co-authored) 13 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
NRG Oncology
ID
NCT03180268
Phase
Phase 3 Meningioma Research Study
Study Type
Interventional
Participants
Expecting 148 study participants
Last Updated